Ardelyx ($ARDX) Insider Trading & Smart Money Activity
Ardelyx, Inc. ($ARDX) has 9 insider trades, 3 13F position changes and 1 analyst rating on file. In the last 12 months on the open market, no insider bought and 2 insiders sold ($726.82K), net -$726.82K.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 2
- Net insider $ (12 mo)
- -$726.82K
- Congress trades (12 mo)
- 0
- 13F moves on file
- 3
- Analyst ratings on file
- 1
ARDX insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 2 · $726.82K | 0 / 0 | 2 / 1 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All ARDX insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Laura WilliamsChief Patient Officer | Sell (Open-market sale) 10b5-1 | 81.90K sh | $490.57K | +0.2% | -15.9% | Read | ||||
| Insider | Laura WilliamsChief Patient Officer | Buy (Option exercise) | 31K sh | $30.69K | +0.2% | -15.9% | — | ||||
| Analyst | Ladenburg Thalmann | Raises to buy | PT $16 | +9.0% | -9.7% | Read | |||||
| Insider | Richard Rodgers | Buy (Grant or award) | 26.45K sh | +9.0% | -9.7% | — | |||||
| Insider | Merdad Parsey | Buy (Grant or award) | 39.72K sh | +9.0% | -9.7% | Read | |||||
| Insider | David Mott | Buy (Grant or award) | 39.72K sh | +9.0% | -9.7% | Read | |||||
| Insider | Bertrand William JR | Buy (Grant or award) | 38.80K sh | +9.0% | -9.7% | — | |||||
| Insider | Robert Bazemore | Buy (Grant or award) | 26.45K sh | +9.0% | -9.7% | — | |||||
| Insider | Michael RaabPresident & CEO | Sell (Open-market sale) 10b5-1 | 41.67K sh | $236.25K | +12.1% | -6.7% | — | ||||
| Insider | Michael RaabPresident & CEO | Buy (Option exercise) | 20.83K sh | $20.62K | +12.1% | -6.7% | — | ||||
| 13F | Two Sigma Advisers | Sold out | -1.35M sh | -1.9% | -8.8% | — | |||||
| 13F | Millennium Management | Added | +5.93M sh | $103.31M | -1.9% | -8.8% | — | ||||
| 13F | Millennium Management | Added | +5.93M sh | $91M | -1.9% | -8.8% | — |
1W / 1M / 6M = how ARDX moved from the trade or filing date.
Insider trading in ARDX: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Laura Williams | Chief Patient Officer | 2 | -$490.57K | Jun 18, 2026 | |
| Richard Rodgers | 1 | — | Jun 16, 2026 | ||
| Merdad Parsey | 1 | — | Jun 16, 2026 | ||
| David Mott | 1 | — | Jun 16, 2026 | ||
| Bertrand William JR | 1 | — | Jun 16, 2026 | ||
| Robert Bazemore | 1 | — | Jun 16, 2026 | ||
| Michael Raab | President & CEO | 2 | -$236.25K | Jun 15, 2026 |
Institutions moving ARDX (13F)
Analyst ratings on ARDX
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Ladenburg Thalmann | Raises | buy | $16 | +9.0% | -9.7% | Read |
Frequently asked questions
Are ARDX insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 2 insiders made 2 open-market sales worth $726.82K, a net -$726.82K.
What is the latest insider trade in ARDX?
Laura Williams, Chief Patient Officer filed a sell (open-market sale) of 81.90K sh worth $490.57K on Jun 18, 2026.
Which institutions changed their ARDX positions?
Recent 13F filers moving the stock include Millennium Management and Two Sigma Advisers.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.